Wheezing
Methodology & AI Transparency ⓘ
Wheezing Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Wheezing (R06.2; Asthma, COPD & Respiratory Disease) utilize vaccination review [Wheezing R06.2] and objective Resting Pulse Oximetry in Wheezing (R06.2: (SpO2)) targets (96% – 100% (R06.2)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Mapped to Asthma, COPD & Respiratory Disease under ICD-10-CM R06.2 for Wheezing clinical workups.
- 3 Typical cash cost range: Differential triage of Wheezing (R06.2) utilizes vaccination review [Wheezing R06.2].
- 4 Top reported side effects / signs: Key Lungs & Asthma biomarkers for Wheezing (R06.2): Resting Pulse Oximetry in Wheezing (R06.2: (SpO2)) & Blood Eosinophil Count [Wheezing R06.2] (< 150 cells/uL (phenotyping marker) (R06.2)).
Ask our AI Specialists anything about Wheezing
What Is Wheezing?
Physicians managing Wheezing (R06.2; Asthma, COPD & Respiratory Disease) utilize vaccination review [Wheezing R06.2] and objective Resting Pulse Oximetry in Wheezing (R06.2: (SpO2)) targets (96% – 100% (R06.2)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
Wheezing (R06.2) alters lungs & asthma homeostasis through mucus goblet-cell hyperplasia [Wheezing R06.2]; clinical remission targets Blood Eosinophil Count [Wheezing R06.2] within < 150 cells/uL (phenotyping marker) (R06.2).
Common Symptoms & Clinical Signs
- • Presentation of Wheezing (R06.2): prolonged recovery from in Wheezing (R06.2: viral respiratory infections)
- • Secondary Wheezing clinical sign: declining stair-climbing stamina in Wheezing (R06.2: or frequent rescue)
- • Symptom flares in Wheezing correlating with Resting Pulse Oximetry in Wheezing (R06.2: (SpO2)) deviation outside 96% – 100% (R06.2)
- • Functional lungs & asthma impact requiring vaccination review [Wheezing R06.2] evaluation (R06.2)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Wheezing Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R06.2 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Asthma, COPD & Respiratory Disease | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Resting Pulse Oximetry in Wheezing (R06.2: (SpO2)) | 96% – 100% (R06.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Blood Eosinophil Count [Wheezing R06.2] | < 150 cells/uL (phenotyping marker) (R06.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Spirometry FEV1 / in Wheezing (R06.2: FVC Ratio) | >= 0.75 (FEV1 >= 80% predicted) (R06.2) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Wheezing
Treatment selection for Wheezing depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Wheezing)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Objectives: To evaluate the real-world benefits and safety of mucosal sublingual immunotherapy based on whole inactivated bacteria (MV130) in preventing WA in children. American journal of respiratory and critical care medicine • 2021-08-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33705665 ↗ |
Wheezing Patient Community & “People Like Me” Threads
Filter Wheezing community threads and patient logs by age, biological sex, dosage, and treatment duration.